MJ MED: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MJ MED
Largest movements
- Current investments +€25,000
new in 2025: €25,000
- Receivables within one year +€7,600
new in 2025: €7,600
- Cash +€2,444
up €2,444 (+38.0%), from €6,435 to €8,879
mainly Net result for the year (+€43,246) and Depreciation (+€1,742)
- Tangible fixed assets -€1,742
down €1,742 (-51.1%), from €3,411 to €1,669
- Profit (loss) carried forward +€43,246
up €43,246, from -€3,637 to €39,609
- Other debts -€10,464
down €10,464 (-95.0%), from €11,012 to €548
- Gross operating margin +€62,847
up €62,847, from -€1,710 to €61,137
- Taxes +€14,650
new in 2025: €14,650
- Other operating charges +€1,156
new in 2025: €1,156
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €9,846 | €43,148 | +€33,302 | +338% |
| Fixed assets | 21/28 | €3,411 | €1,669 | -€1,742 | -51.1% |
| Tangible fixed assets | 22/27 | €3,411 | €1,669 | -€1,742 | -51.1% |
| Furniture and vehicles | 24 | €3,411 | €1,669 | -€1,742 | -51.1% |
| Current assets | 29/58 | €6,435 | €41,479 | +€35,044 | +545% |
| Amounts receivable within one year | 40/41 | - | €7,600 | +€7,600 | |
| Other amounts receivable | 41 | - | €7,600 | +€7,600 | |
| Current investments | 50/53 | - | €25,000 | +€25,000 | |
| Cash at bank and in hand | 54/58 | €6,435 | €8,879 | +€2,444 | +38.0% |
| Total equity and liabilities | 10/49 | €9,846 | €43,148 | +€33,302 | +338% |
| Equity | 10/15 | -€2,137 | €41,109 | +€43,246 | |
| Contributions | 10/11 | €1,500 | €1,500 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€3,637 | €39,609 | +€43,246 | |
| Amounts payable | 17/49 | €11,983 | €2,039 | -€9,944 | -83.0% |
| Amounts payable within one year | 42/48 | €11,983 | €2,039 | -€9,944 | -83.0% |
| Trade debts | 44 | €371 | €791 | +€420 | +113% |
| Suppliers | 440/4 | €371 | €791 | +€420 | +113% |
| Taxes, remuneration and social security | 45 | €600 | €700 | +€100 | +16.7% |
| Taxes | 450/3 | €600 | €700 | +€100 | +16.7% |
| Other amounts payable | 47/48 | €11,012 | €548 | -€10,464 | -95.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €1,815 | €1,742 | -€74 | -4.1% |
| Other operating charges | 640/8 | - | €1,156 | +€1,156 | |
| Gross operating margin | 9900 | -€1,710 | €61,137 | +€62,847 | |
| Operating profit (loss) | 9901 | -€3,525 | €58,239 | +€61,765 | |
| Financial charges | 65/66B | €112 | €344 | +€232 | +207% |
| Recurring financial charges | 65 | €112 | €344 | +€232 | +207% |
| Profit (loss) for the period before taxes | 9903 | -€3,637 | €57,896 | +€61,533 | |
| Income taxes | 67/77 | - | €14,650 | +€14,650 | |
| Profit (loss) for the period | 9904 | -€3,637 | €43,246 | +€46,883 | |
| Profit (loss) for the period to be appropriated | 9905 | -€3,637 | €43,246 | +€46,883 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 21 October 2026 via checked.be.